You searched for metabolic diseases - Page 26 of 63

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

…been used to treat rare genetic diseases. As the field of oncology explores new ways to harness the immune system’s potential, Vironexis’ approach could represent a shift toward more streamlined,…

September 16, 2024 - 6 minutesmins - By Jules Adam

Best in Biotech 23 May 2024

10 notable pharma and biotech venture capital arms

…Rome Therapeutics to support clinical development for autoimmune diseases, and a PIPE investment in Nanobiotix, a clinical-stage biotechnology company focused on developing product candidates using proprietary nanotechnology to increase the…

May 23, 2024 - 10 minutesmins - By Willow Shah-Neville

spark therapeutics genable gene therapy blindness pigmentosa rhonova

News and Trends 8 Mar 2016

Irish Gene Therapy for Blindness is Acquired by US Leader in the Field

…innovative approach to the treatment of autosomal dominant diseases. For these types of genetic diseases, having only one copy of a mutated gene can lead to developing symptoms (even if…

March 8, 2016 - 3 minutesmins - By Denise Neves Gameiro

geneva biotech serono university of geneva

Best in Biotech 30 May 2017

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

…health research. Notable examples include FIND, which develops diagnostic tests for infectious diseases, Drugs for Neglected Diseases Initiative, and Medicines for Malaria Venture, which has succeeded in raising over $890M…

May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro

Best in Biotech 18 Jun 2024

5 companies spearheading the emerging biotech scene in the Balkans

…lead identification and lead optimization phases. ResQ Biotech Greek company ResQ Biotech is advancing early-stage drug discovery for diseases caused by protein misfolding and aggregation. Protein misfolding diseases (PMDs) are…

June 18, 2024 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 26 Jun 2023

Five animal health companies you should know about

…25% in 2010. Dalan Animal Health American foulbrood (AFB) is one of the most devastating and fatal diseases known to affect honeybee brood, weakening and killing honeybee colonies. It is…

June 26, 2023 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 16 Apr 2025

HIV innovation: Six companies developing new treatments in 2025

Over four decades since its discovery, human immunodeficiency virus (HIV) remains one of the most challenging infectious diseases. Antiretroviral therapy (ART) has turned HIV from a fatal diagnosis into a…

April 16, 2025 - 9 minutesmins - By Jules Adam

News and Trends 21 Jun 2018

Gene Editing Could Cut the Cost of One of the Most Expensive Animal Diseases in the World

…Edinburgh, in collaboration with the animal genetics company Genus, have produced pigs that are resistant to one of the most costly animal diseases in the world using genetic engineering. This…

June 21, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 24 May 2018

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

…and Asia, could benefit research into treatments for diseases such as cancer and Alzheimer’s. PhysioMimix, an organ-on-a-chip device, has open-well plates in which cells or pre-formed tissues can be placed…

May 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 17 May 2023

Diagnosing inflammatory diseases with synthetic peptides

…translate the assay into a product that can bring the diagnostic power of this increasingly important biomarker to a new level to help patients suffering from inflammatory diseases,” Heinis said….

May 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 2 Oct 2024

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

…resources and a team of disease specialists. The push to develop drugs for rare diseases Janet Maynard, director of CDER’s Office of Rare Diseases, Pediatrics, Urologic, and Reproductive Medicine, said…

October 2, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 25 May 2023

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

…to improved selectivity and ultimately reduce attrition rates. The aim is to develop therapies that are highly effective with fewer side effects to treat diseases with a high clinical need….

May 25, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

10 notable pharma and biotech venture capital arms

Irish Gene Therapy for Blindness is Acquired by US Leader in the Field

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

5 companies spearheading the emerging biotech scene in the Balkans

Five animal health companies you should know about

HIV innovation: Six companies developing new treatments in 2025

Gene Editing Could Cut the Cost of One of the Most Expensive Animal Diseases in the World

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

Diagnosing inflammatory diseases with synthetic peptides

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!